Measles and rubella elimination: communicating the importance of vaccination
The goal of this project is to support EU Member States in their fight against measles and rubella. This report should enable Member States to engage in effective, evidence-based risk communication.
The goal of this project is to support EU Member States in their fight against measles and rubella. More specifically, this project aims to:
- dispel the myths about measles vaccination;
- offer scientific, evidence-based corrections of misperceptions on measles
- inform about rubella infections in pregnancy; and
- discuss the risks and benefits of vaccination against rubella for women of childbearing age.
This report should enable Member States to engage in effective, evidence-based risk communication. Information on measles and rubella is presented in a modular fashion, so it can be easily used in customised leaflets, flyers, or web pages. The facts presented in this report are intended to lower the barriers to measles and rubella vaccination and raise awareness for congenital rubella syndrome (CRS), including awareness for ante-natal screenings and post-partum vaccination.
Generic protocol for COVID-19 vaccine effectiveness studies during outbreaks in semi-closed settings in the EU/EEA
14 Dec 2021 - ECDC encourages the use of this protocol as a basis for studies aiming at assessing vaccine effectiveness in semi-closed settings following the identification of a COVID-19 outbreak, as its use in the EU/EEA can facilitate results comparability from different outbreak investigations.
Interim public health considerations for COVID-19 vaccination of children aged 5-11 years
1 Dec 2021 - This technical report provides a set of interim public health considerations to support EU/EEA public health authorities taking decisions on the administration of COVID-19 vaccines to children aged 5 11 years.
Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA
11 Nov 2021 - This report provides an updated overview of the progress of national COVID-19 vaccination strategies in EU/EEA countries, including updates on: vaccine uptake overall and by target group; vaccination strategies and policies in place; vaccine acceptance and hesitancy; and challenges countries face with increasing uptake and good practices to mitigate these challenges.